1. DPYSL5 is highly expressed in treatment-induced neuroendocrine prostate cancer and promotes lineage plasticity via EZH2/PRC2
   Roosa Kaarijärvi et al, 2024, Communications Biology CrossRef
2. Anlotinib induces neuronal‐like differentiation of neuroblastoma by downregulating CRMP5
   Junwen Hu et al, 2024, Molecular Carcinogenesis CrossRef
3. The pharmacological and biological importance of EZH2 signaling in lung cancer
   Maliheh Entezari et al, 2023, Biomedicine & Pharmacotherapy CrossRef